Your browser doesn't support javascript.
loading
Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.
Sivapalaratnam, Suthesh; Westbury, Sarah K; Stephens, Jonathan C; Greene, Daniel; Downes, Kate; Kelly, Anne M; Lentaigne, Claire; Astle, William J; Huizinga, Eric G; Nurden, Paquita; Papadia, Sofia; Peerlinck, Kathelijne; Penkett, Christopher J; Perry, David J; Roughley, Catherine; Simeoni, Ilenia; Stirrups, Kathleen; Hart, Daniel P; Tait, R Campbell; Mumford, Andrew D; Laffan, Michael A; Freson, Kathleen; Ouwehand, Willem H; Kunishima, Shinji; Turro, Ernest.
Afiliación
  • Sivapalaratnam S; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Westbury SK; National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Stephens JC; Department of Haematology, Barts Health National Health Service Trust, London, United Kingdom.
  • Greene D; School of Clinical Sciences, University of Bristol, Bristol, United Kingdom.
  • Downes K; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Kelly AM; National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Lentaigne C; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Astle WJ; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Huizinga EG; National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Nurden P; Medical Research Council Biostatistics Unit, Cambridge Institute of Public Health, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Papadia S; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Peerlinck K; National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Penkett CJ; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Perry DJ; Department of Haematology, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom.
  • Roughley C; Centre for Haematology, Hammersmith Campus, Imperial College Academic Health Sciences Centre, Imperial College London, London, United Kingdom.
  • Simeoni I; Imperial College Healthcare National Health Service Trust, London, United Kingdom.
  • Stirrups K; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Hart DP; National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Tait RC; Medical Research Council Biostatistics Unit, Cambridge Institute of Public Health, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Mumford AD; Crystal and Structural Chemistry, Department of Chemistry, Faculty of Science, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
  • Laffan MA; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Freson K; National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Ouwehand WH; Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.
  • Kunishima S; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Turro E; National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
Blood ; 129(4): 520-524, 2017 01 26.
Article en En | MEDLINE | ID: mdl-28064200
ABSTRACT
The von Willebrand receptor complex, which is composed of the glycoproteins Ibα, Ibß, GPV, and GPIX, plays an essential role in the earliest steps in hemostasis. During the last 4 decades, it has become apparent that loss of function of any 1 of 3 of the genes encoding these glycoproteins (namely, GP1BA, GP1BB, and GP9) leads to autosomal recessive macrothrombocytopenia complicated by bleeding. A small number of variants in GP1BA have been reported to cause a milder and dominant form of macrothrombocytopenia, but only 2 tentative reports exist of such a variant in GP1BB By analyzing data from a collection of more than 1000 genome-sequenced patients with a rare bleeding and/or platelet disorder, we have identified a significant association between rare monoallelic variants in GP1BB and macrothrombocytopenia. To strengthen our findings, we sought further cases in 2 additional collections in the United Kingdom and Japan. Across 18 families exhibiting phenotypes consistent with autosomal dominant inheritance of macrothrombocytopenia, we report on 27 affected cases carrying 1 of 9 rare variants in GP1BB.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trombocitopenia / Plaquetas / Complejo GPIb-IX de Glicoproteína Plaquetaria / Hemorragia / Mutación Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trombocitopenia / Plaquetas / Complejo GPIb-IX de Glicoproteína Plaquetaria / Hemorragia / Mutación Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido